Vor Biopharma Inc (NASDAQ: VOR) on Tuesday, plunged -3.04% from the previous trading day, before settling in for the closing price of $0.66. Within the past 52 weeks, VOR’s price has moved between $0.63 and $3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 11.93%. With a float of $59.59 million, this company’s outstanding shares have now reached $67.89 million.
In an organization with 168 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 60.54%, operating margin of -1020.78%, and the pretax margin is -965.93%.
Vor Biopharma Inc (VOR) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vor Biopharma Inc is 12.87%, while institutional ownership is 68.94%. The most recent insider transaction that took place on Jun 03 ’24, was worth 20,357. In this transaction CHIEF MEDICAL OFFICER of this company sold 14,645 shares at a rate of $1.39, taking the stock ownership to the 96,063 shares.
Vor Biopharma Inc (VOR) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.49 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.47) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.93% per share during the next fiscal year.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Vor Biopharma Inc (VOR) is currently performing well based on its current performance indicators. A quick ratio of 6.54 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.74, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.20 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.38 million. That was inferior than the volume of 0.5 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.98%. Additionally, its Average True Range was 0.07.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 1.30%, which indicates a significant decrease from 8.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.41% in the past 14 days, which was lower than the 72.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8448, while its 200-day Moving Average is $1.5183. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $0.6696. Second resistance stands at $0.6949. The third major resistance level sits at $0.7120. If the price goes on to break the first support level at $0.6272, it is likely to go to the next support level at $0.6101. Assuming the price breaks the second support level, the third support level stands at $0.5848.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
Market capitalization of the company is 44.07 million based on 68,260K outstanding shares. Right now, sales total 0 K and income totals -117,863 K. The company made 0 K in profit during its latest quarter, and -27,839 K in sales during its previous quarter.
